Convexia

San Francisco, United States

Convexia develops AI agents that evaluate drug assets through simulations, clinical profiling, safety prediction, and market analysis.

$500K raised

Sep 2025

Pre-Seed

Top Investors

Y CombinatorRebel Fund

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Convexia raised?

Convexia has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2025.

Who are Convexia's investors?

Convexia's investors include Y Combinator, Rebel Fund.

Where is Convexia headquartered?

Convexia is headquartered in San Francisco, United States.

What does Convexia do?

Convexia develops AI agents that evaluate drug assets through simulations, clinical profiling, safety prediction, and market analysis.

What stage is Convexia at?

Convexia is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 9, 2025.

MLA

"Convexia — Funding & Investors." VCBacked, September 9, 2025, https://www.vcbacked.co/company/convexia. Accessed June 4, 2026.

APA

VCBacked. (2025). Convexia — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/convexia

Wikipedia (cite web)

{{cite web |title=Convexia — Funding & Investors |url=https://www.vcbacked.co/company/convexia |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 9, 2025.